Tepha Revenue and Competitors

Boston, MA USA

Location

$60.2M

Total Funding

Estimated Revenue & Valuation

  • Tepha's estimated annual revenue is currently $2.8M per year.(i)
  • Tepha's estimated revenue per employee is $125,500
  • Tepha's total funding is $60.2M.

Employee Data

  • Tepha has 22 Employees.(i)
  • Tepha grew their employee count by -4% last year.

Tepha's People

NameTitleEmail/Phone
1
DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.8M393%N/AN/A
#2
$8.5M343%N/AN/A
#3
$3M12-29%N/AN/A
#4
$5630M7477-11%$450MN/A
#5
$4.5M186%N/AN/A
#6
$7.2M5727%$29.6MN/A
#7
$14.3M57-12%N/AN/A
#8
$2.3M186%$44MN/A
#9
$40.7M162-1%N/AN/A
#10
$45.7M182-5%N/AN/A
Add Company

What Is Tepha?

Tepha was incorporated in 1998 following a successful collaboration between our sister company, Metabolix, Inc. (Cambridge, MA) & Children’s Hospital, Boston in project involving cardiovascular tissue engineering. Surgeons at Children’s Hospital had been attempting to develop a tissue engineered heart valve that could grow with the patient. Such a product would represent a quantum leap in heart valve surgery for the pediatric population, eliminating the need to replace the valve after a few yrs. Using the Company’s proprietary technology, Tepha was able to successfully produce a biomaterial scaffold suitable for tissue engineered valves. The results of subsequent experiments were astounding. It was found that newly implanted valves grew with their recipients, & its scaffolds completely remodeled into new heart valve tissue that resembled the native tissues within 6 to 8 weeks.

keywords:Healthcare

$60.2M

Total Funding

22

Number of Employees

$2.8M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Tepha News

2022-04-17 - Polypropylene Mesh Market Size, Outlook And Forecast ...

... Mesh Market Size, Outlook And Forecast | Ethicon, ALTAYLAR MEDICAL, Bio-Rad, Molnlycke Healthcare, C.R. Bard, Tepha, Atrium, Medtronic.

2022-03-30 - Channel Medsystems Announces Appointment of Three Key Executives to Management Team and Expanded Launch of Cerene® Cryotherapy for Heavy Menstrual Bleeding

Most recently, Ian was Vice President and Chief Financial Officer of Tepha, Inc. (acquired by Becton, Dickson and Company), a proprietary...

2010-07-16 - Tepha Receives $3.2M Credit Facility from GE Capital

Tepha, Inc., a Lexington, MA-based developer of medical devices derived from a new class of resorbable polymers that have been engineered utilizing recombinant DNA technology, has received a $3.2m credit facility from GE Capital, Healthcare Financial Services. The financing provides the company ...

2010-02-04 - Tepha stitches up $3 million equity sale

Tepha Inc. stitched up nearly $3 million in new funding from a group of un-named investors, according to a filing with the federal Securities and Exchange Commission. The Lexington, Mass.-based company, a 1998 spinout from Cambridge, Mass.-based Metabolix (NSDQ:MBLX), is developing absorbable p ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A22-12%N/A
#2
$3.4M22-59%N/A
#3
$3.8M22-12%N/A
#4
$3.4M225%N/A
#5
$3.2M22-8%N/A